Here, Seegene introduced its 5 major molecular diagnostic products: Anyplex™II RV16 Detection which simultaneously detects 16 different respiratory viruses, Anyplex™II RB5 Detection which simultaneously detects 5 different respiratory bacteria, Anyplex™II MTB/MDR/XDR Detection which simultaneously detects MTB, MDR-TB, and XDR-TB, Anyplex™II HPV 28 Detection which simultaneously detects 28 different HPVs, and Anyplex™II STI-7 Detection which simultaneously detects 7 STI causing pathogens.These products use the TOCE™ technology, enabling the amplification of multiple target genes at the same time.Seegene was also able to draw attention by showing how the time to extract samples, amplify gene, and analyze results was reduced due to Seegene’s automated system. This was possible with the help of the Saudi Arabian agent, which is Seegene’s main partner in the Middle East.

With the TOCE™ technology, which overcame many technical limitations in former real time gene amplification devices, enabling the multiplex real-time PCR technology, and the automation of the molecular diagnostic process, the Seegene booth experienced one of its highest turnout rates.

The team manager of the Overseas Business Division whom also participated in this exhibition stated that, “Arab Health is not only a good opportunity to display our products, but also an excellent chance to explore candidates for agencies in the Middle East, Africa, and Asia. It will be a valuable experience to further strengthen our relationships with our main partners and expand our current market in the Middle East.”